On a systems level, HCW concerns include lack of time during consultations (16– 18), lack of training for HCWs, both prequalification and in-service (17, 19), weak referral networks (16, 17, 19), lack of confidence in management support (20), insufficient flexibility, and policy constraints (10).
This remuneration may be offered by markets (such as balancing markets, intraday and day-ahead markets) or policy instruments, and it may be tied to the fulfilment of predefined criteria (e.g. prequalification requirements in balancing markets, technical requirements in the EEG).
Their product, used in the AQUAMAT and SEAQUAMT trials, 7 8 only gained WHO prequalification status in November 2010. 10 Production is increasing worldwide but parenteral artesunate remains unlicensed for use in the UK.
Export license was granted in December 2009, and WHO prequalification was obtained in June 2010.
WHO continued its review of the dossier, and WHO prequalification for use in 1- to 29-year-olds was granted in June 2010 [ 7].
One is the prequalification programme, established in 2001 on behalf of the United Nations, which aims to ensure access to medicines that meet specified standards of quality, safety and efficacy, mainly for HIV/AIDS, malaria, tuberculosis and reproductive health 148.
The IVI staff facilitated the transfer of the technology to Shantha Biotechnics in India which had been successful in obtaining WHO prequalification for other vaccines.
It was successful and resulted in the WHO prequalification of 2 products, a PsA-TT 10-µg vaccine for use in mass vaccination campaigns among 1- to 29-year-olds, and a 5-µg vaccine for use in routine immunization programs among children <2 years of age.
Buyers working with a broker should also ask which lenders the broker knows are issuing which kinds of letters, and whether having just a prequalification will affect their chances of putting in a winning bid on a property.
Elaborating on market entry difficulties, they pointed out that Ó with new medicines taking between 3 to 5 years after FDA or EMEA approval to launch in developing countries, as it requires inclusion in WHO treatment guidelines, prequalification and multiple registrations - the attractiveness of the market is further curtailed.
